Video from AACC: PerkinElmer on diagnostics, acquisitions Greg Stock, general manager of PerkinElmer’s Euroimmun business, discussed products and technologies on display at AACC 2022, as well as the integration of acquired companies such as Oxford Immunotec.Read More
Video from AACC: Reducing sequencing complexity Clear Labs Chief Commercial Officer Jeff Field and Director of Assay Development Prasanna Thwar sat down with LabPulse.com (sister site of ScienceBoard.net) to discuss the launch of a platform that makes DNA sequencing easier by integrating robotic automation and cloud-based computing.Read More
Video from AACC: Highlights of Day 3 Highlights from the LabPulse.com (sister site of ScienceBoard.net) team for Day 3 of the American Association for Clinical Chemistry (AACC) 2022 Chicago meeting.Read More
New DNA editing tool could enable more personalized cell therapies University of Minnesota, Twin Cities researchers have developed a new tool to predict and customize the rate of a type of DNA editing called site-specific recombination, offering the potential for more personalized cell therapies.Read More
Repetitive DNA linked to cancer formation in study of replication process Researchers have discovered that noncoding "junk" DNA could potentially contribute to the development of cancer. Repetitive DNA sequences can cause replication to stall, triggering a response that is similar to the one induced by DNA damage, according to a study published July 19 in Nature Communications.Read More
Machine learning model opens door to real-time detection of cell therapy contamination Researchers at the Massachusetts Institute of Technology’s Singapore site have developed a new way to detect adventitious microbial contamination in mesenchymal stromal cell cultures. By using machine learning to predict if a culture is contaminated in near real-time, the approach could enable testing to take place during the production of cell therapy products.Read More